Skip to main content
Clinical Trials/ISRCTN32148715
ISRCTN32148715
Active, Not Recruiting
N/A

Comparative evaluation of cardiovascular rehabilitation programs in patients after transcutaneous aortic valve replacement; with evaluation of ergospirometric, functional, imaging and biochemical data and markers

niversity of West Attica0 sites75 target enrollmentFebruary 10, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiovascular rehabilitation in patients after TAVI
Sponsor
niversity of West Attica
Enrollment
75
Status
Active, Not Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 10, 2023
End Date
December 30, 2024
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of West Attica

Eligibility Criteria

Inclusion Criteria

  • 1\. Men and women aged 60\-85 years
  • 2\. Will have undergone TAVI within a period of time 6 months before starting the cardiovascular rehabilitation program
  • 3\. Functional class of heart failure I to III, according to the functional classification of the New York Heart Association (NYHA)
  • 4\. Patients will be under medication and should have an ejection fraction (EF) \=40%
  • 5\. Willing to be assigned to the study

Exclusion Criteria

  • 1\. Patients with severe\-grade coronary artery disease
  • 2\. Genetic and non\-genetic diseases that cause systolic or diastolic dysfunction
  • 3\. History of thromboembolic and vascular events diseases
  • 4\. Patients with an individual history of syncope fainting episodes and dangerous arrhythmias
  • 5\. Autoimmune patients or endocrinological diseases
  • 6\. Respiratory ailments
  • 7\. Neoplastic, hepatic, nephrological and infectious disease
  • 8\. Patients with disorders affecting the ability to exercise

Outcomes

Primary Outcomes

Not specified

Similar Trials